Amkor Technology beats Q3 expectations, expands fan-out packaging for AI and high-performance computing, and plans to return 40–50% of free cash flow to shareholders.
Multiple comets, including the rare interstellar comet 3I/ATLAS, brightened the October 2025 skies, captivating astronomers and the public.
US obesity declines as GLP-1 drug use rises, with potential benefits beyond weight loss.
Amkor Technology beats Q3 expectations, expands fan-out packaging for AI and high-performance computing, and plans to return 40–50% of free cash flow to shareholders.
Multiple comets, including the rare interstellar comet 3I/ATLAS, brightened the October 2025 skies, captivating astronomers and the public.
US obesity declines as GLP-1 drug use rises, with potential benefits beyond weight loss.